Total Shoulder Arthroplasty Clinical Trial
— pTSAOfficial title:
Posterior Approach to Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing the Posterior Approach to Total Shoulder Arthroplasty
Verified date | May 2019 |
Source | The Orthopaedic Research & Innovation Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to evaluate preoperative objective measurements and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.
Status | Active, not recruiting |
Enrollment | 31 |
Est. completion date | December 31, 2024 |
Est. primary completion date | August 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. English speaking 2. >18 years of age 3. Underwent posterior approach to total shoulder arthroplasty by Dr. Michael Greiwe at St. Elizabeth Healthcare Exclusion Criteria: 1. Non-English speaking 2. <18 years of age 3. Loose bone in the anterior recess of the shoulder 4. Severe arthritis with significant bony deformity |
Country | Name | City | State |
---|---|---|---|
United States | The Orthopaedic Research & Innovation Foundation | Edgewood | Kentucky |
Lead Sponsor | Collaborator |
---|---|
The Orthopaedic Research & Innovation Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | recovery | American shoulder and elbow score (ASES) with a range from 0-100, with 0 being worst outcome and 100 being best outcome | preoperative to 6 months postoperatively | |
Primary | recovery | Simple Shoulder Test score (SST) with a range from 0-12 with 12 being the best score and 0 being the worst score. | preoperative to 6 months postoperatively | |
Primary | recovery | range of motion | preoperative to 6 months postoperatively | |
Primary | complications | percent of complications | 6 months postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05900427 -
Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients
|
Phase 4 | |
Completed |
NCT01430468 -
Patient Specific Instruments Versus Standard Surgical Instruments
|
N/A | |
Completed |
NCT03730597 -
Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study
|
N/A | |
Completed |
NCT01782872 -
Analgesia After Total Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT06109415 -
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
|
Phase 4 | |
Terminated |
NCT03219983 -
Pain Management After Total Shoulder Arthroplasty
|
Phase 4 | |
Completed |
NCT01726972 -
A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
|
||
Enrolling by invitation |
NCT06133933 -
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
|
||
Completed |
NCT04855019 -
Post Surgical Pain in Arthroscopic Shoulder
|
N/A | |
Suspended |
NCT04416932 -
Ultrasound After Total Shoulder Arthroplasty
|
||
Recruiting |
NCT06143306 -
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
|
Phase 4 | |
Completed |
NCT03887650 -
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
|
Phase 4 | |
Recruiting |
NCT05068960 -
Postoperative Pain Control in Total Shoulder Arthroplasty
|
Phase 4 | |
Active, not recruiting |
NCT02143245 -
Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections
|
N/A | |
Completed |
NCT01550952 -
Interscalene Dynamometer Pilot Study
|
N/A | |
Completed |
NCT03969875 -
Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
|
||
Completed |
NCT04364867 -
Exparel for Total Shoulder Arthroplasty
|
Phase 4 |